1. Ishizuka, S. et al. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mecha- nism independent of extracellular hyaluronan. J. Biol. Chem. 294, 13562–13579. https://doi.org/10.1074/jbc.RA119.008567 (2019).
2. Terabe, K. et al. Chondroprotective effects of 4-methylumbelliferone and hyaluronan synthase-2 overexpression involve changes in chondrocyte energy metabolism. J. Biol. Chem. 294, 17799–17817. https://doi.org/10.1074/jbc.RA119.009556 (2019).
3. Warburg, O. On respiratory impairment in cancer cells. Science 124, 269–270 (1956).
4. Ishizuka, S., Askew, E. B., Ishizuka, N., Knudson, C. B. & Knudson, W. 4-Methylumbelliferone diminishes catabolically acti- vated articular chondrocytes and cartilage explants via a mechanism independent of hyaluronan inhibition. J. Biol. Chem. 291, 12087–12104. https://doi.org/10.1074/jbc.M115.709683 (2016).
5. Frey, P. A. The Leloir pathway: A mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 10, 461–470 (1996).
6. Aguer, C. et al. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PLoS ONE 6, e28536. https://doi.org/10.1371/journal.pone.0028536 (2011).
7. Reitzer, L. J., Wice, B. M. & Kennell, D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669–2676 (1979).
8. Robinson, B. H., Petrova-Benedict, R., Buncic, J. R. & Wallace, D. C. Nonviability of cells with oxidative defects in galactose medium: A screening test for affected patient fibroblasts. Biochem. Med. Metab. Biol. 48, 122–126. https://doi.org/10.1016/0885- 4505(92)90056-5 (1992).
9. Li, X. et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol. 6, 19. https://doi.org/10.1186/1756-8722-6-19 (2013).
10. Poderoso, J. J., Helfenberger, K. & Poderoso, C. The effect of nitric oxide on mitochondrial respiration. Nitric Oxide 88, 61–72. https://doi.org/10.1016/j.niox.2019.04.005 (2019).
11. Kolpen, M. et al. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen. Clin. Exp. Immunol. 177, 310–319. https://doi.org/10.1111/cei.12318 (2014).
12. Terkeltaub, R., Yang, B., Lotz, M. & Liu-Bryan, R. Chondrocyte AMP-activated protein kinase activity suppresses matrix degrada- tion responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α. Arthritis Rheum 63, 1928–1937. https:// doi.org/10.1002/art.30333 (2011).
13. Tan, Z. et al. The role of PGC1α in cancer metabolism and its therapeutic implications. Mol. Cancer Ther. 15, 774–782. https://doi. org/10.1158/1535-7163.Mct-15-0621 (2016).
14. Zhang, L. N. et al. Novel small-molecule PGC-1α transcriptional regulator with beneficial effects on diabetic db/db mice. Diabetes 62, 1297–1307. https://doi.org/10.2337/db12-0703 (2013).
15. Wang, M. et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15, R5. https://doi.org/ 10.1186/ar4133 (2013).
16. Mobasheri, A. et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 13, 302–311. https://doi. org/10.1038/nrrheum.2017.50 (2017).
17. Liu-Bryan, R. Inflammation and intracellular metabolism: New targets in OA. Osteoarthritis Cartilage 23, 1835–1842. https://doi. org/10.1016/j.joca.2014.12.016 (2015).
18. Tchetina, E. V. & Markova, G. A. Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes. Rheumatol. Int. 38, 1963–1974. https://doi.org/10.1007/s00296-018-4103-4 (2018).
19. June, R. K., Liu-Bryan, R., Long, F. & Griffin, T. M. Emerging role of metabolic signaling in synovial joint remodeling and osteo- arthritis. J. Orthop. Res. 34, 2048–2058. https://doi.org/10.1002/jor.23420 (2016).
20. Grishko, V. et al. Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J. Biol. Chem. 284, 9132–9139. https://doi.org/10.1074/jbc.M804178200 (2009).
21. Knudson, W., Ishizuka, S., Terabe, K., Askew, E. B. & Knudson, C. B. The pericellular hyaluronan of articular chondrocytes. Matrix Biol. 78–79, 32–46. https://doi.org/10.1016/j.matbio.2018.02.005 (2019).
22. Rosenberg, J. H., Rai, V., Dilisio, M. F., Sekundiak, T. D. & Agrawal, D. K. Increased expression of damage-associated molecular patterns (DAMPs) in osteoarthritis of human knee joint compared to hip joint. Mol. Cell Biochem. 436, 59–69. https://doi.org/10. 1007/s11010-017-3078-x (2017).
23. Schaefer, L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J. Biol. Chem. 289, 35237–35245. https://doi.org/10.1074/jbc.R114.619304 (2014).
24. Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D. & Will, Y. Circumventing the Crabtree effect: Replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol. Sci. 97, 539–547. https://doi.org/10. 1093/toxsci/kfm052 (2007).
25. Diaz-Ruiz, R., Rigoulet, M. & Devin, A. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim. Biophys. Acta 568–576, 2011. https://doi.org/10.1016/j.bbabio.2010.08.010 (1807).
26. Leloir, L. F. Two decades of research on the biosynthesis of saccharides. Science 172, 1299–1303. https://doi.org/10.1126/science. 172.3990.1299 (1971).
27. Graham, N. A. et al. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol. Syst. Biol. 8, 589. https://doi.org/10.1038/msb.2012.20 (2012).
28. Gavriilidis, C., Miwa, S., von Zglinicki, T., Taylor, R. W. & Young, D. A. Mitochondrial dysfunction in osteoarthritis is associated with down-regulation of superoxide dismutase 2. Arthritis Rheum 65, 378–387. https://doi.org/10.1002/art.37782 (2013).
29. Warburg, O., Geissler, A. W. & Lorenz, S. On growth of cancer cells in media in which glucose is replaced by galactose. Hoppe Seylers Z Physiol. Chem. 348, 1686–1687 (1967).
30. Tsuchiya, S. et al. Suppression of murine osteoarthritis by 4-methylumbelliferone. J. Orthop. Res. 38, 1122–1131. https://doi.org/ 10.1002/jor.24541 (2020).
31. Farndale, R. W., Sayers, C. A. & Barrett, A. J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res. 9, 247–248. https://doi.org/10.3109/03008208209160269 (1982).
32. Ono, Y., Ishizuka, S., Knudson, C. B. & Knudson, W. Chondroprotective effect of kartogenin on CD44-mediated functions in articular cartilage and chondrocytes. Cartilage 5, 172–180. https://doi.org/10.1177/1947603514528354 (2014).
33. Rasmussen, T. B., Uttenthal, A., de Stricker, K., Belák, S. & Storgaard, T. Development of a novel quantitative real-time RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus. Arch Virol. 148, 2005–2021. https://doi.org/ 10.1007/s00705-003-0145-2 (2003).
34. Han, H. S., Qiao, Y., Karabiyikoglu, M., Giffard, R. G. & Yenari, M. A. Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J. Neurosci. 22, 3921–3928. https:// doi.org/10.1523/jneurosci.22-10-03921.2002 (2002).
35. Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156–167. https://doi.org/10.1038/nrd2466 (2008).
36. Kanda, Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl. 48, 452–458. https://doi.org/10.1038/bmt.2012.244 (2013).